What is the recommended dose of ceftriaxone (Ceftriaxone) as the first-line treatment for patients with fever and a positive typhoid test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dose of Ceftriaxone for Typhoid Fever Treatment

For patients with fever and a positive typhoid test, the recommended dose of ceftriaxone is 50-80 mg/kg/day (maximum 2g/day) intravenously or intramuscularly for 5-7 days. 1, 2

First-line Treatment Options

  • Ceftriaxone is an appropriate first-line parenteral therapy for typhoid fever, particularly in areas with high fluoroquinolone resistance 1, 2
  • For adults, a standard dose of 1-2g daily is recommended, while children should receive 50-80 mg/kg/day 1, 3
  • Treatment duration should typically be 5-7 days, though this may be extended in complicated cases 1, 4
  • A flexible-duration approach can be used, continuing ceftriaxone for 5 days after defervescence (fever resolution) 3

Dosing Based on Patient Age

  • Adults: 1-2g IV/IM daily for 5-7 days 1, 2
  • Children: 50-80 mg/kg/day IV/IM (maximum 2g/day) for 5-7 days 1, 5
  • Neonates: Not typically indicated as typhoid fever is rare in this age group, but if needed: 50 mg/kg/day given every 24 hours 1

Administration Considerations

  • Ceftriaxone can be administered as a once-daily dose, which simplifies treatment regimens 5
  • For severe cases requiring hospitalization, initial intravenous administration is preferred 1, 2
  • Once clinical improvement occurs, transition to oral therapy (such as azithromycin) may be considered 2, 6

Clinical Response and Monitoring

  • Mean defervescence (fever resolution) time with ceftriaxone is approximately 4-5 days 7, 4
  • Blood cultures typically become negative earlier with ceftriaxone compared to other treatments like chloramphenicol 4
  • Therapeutic blood levels of ceftriaxone remain well above the MICs for Salmonella typhi strains throughout the 24-hour dosing interval 8

Alternative Treatment Options

  • In areas with high fluoroquinolone resistance, azithromycin (20 mg/kg/day, maximum 1g/day) for 7 days is another recommended first-line option 2, 6
  • For fully susceptible strains, fluoroquinolones remain effective alternatives 2, 6
  • In severe cases, adding steroids may be helpful 1

Important Considerations and Pitfalls

  • Always obtain blood cultures before starting antibiotics when possible, as they have the highest yield within the first week of symptom onset 1, 6
  • Be aware that over 70% of S. typhi and S. paratyphi isolates imported into the UK are resistant to fluoroquinolones, making ceftriaxone or azithromycin better empiric choices 1
  • Prolonged fever despite appropriate treatment can occur in some patients treated with ceftriaxone and should not necessarily prompt a change in therapy unless clinical deterioration occurs 4
  • Relapse rates with ceftriaxone are generally lower (<8%) compared to some other treatments 1, 3

Special Populations

  • For pregnant patients, ceftriaxone is generally considered safe and effective 2
  • For patients with severe hepatic or renal impairment, dose adjustments may be necessary 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Azithromycin for Typhoid Fever Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ceftriaxone therapy in bacteremic typhoid fever.

Antimicrobial agents and chemotherapy, 1985

Research

Pharmacokinetics of ceftriaxone in patients with typhoid fever.

Antimicrobial agents and chemotherapy, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.